Alcon Research, LLC
1 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (1)
- Inspections (2)
Devices registered here (2)
- Lens, Contact, (Disposable)Product code MVN (opens in a new tab) · Class II · Ophthalmic · 21 CFR 886.5925
- Lenses, Soft Contact, Daily WearProduct code LPL (opens in a new tab) · Class II · Ophthalmic · 21 CFR 886.5925
Recalls & enforcement
- Class IITerminated2018-07-17Potential for the optical head to detach from the stand due to the lack of thread adhesive.
FDA inspections (2)
- NAI2019-10-24No Action Indicated · Bioresearch Monitoring
- NAI2016-01-28No Action Indicated · Project Evaluation: Devices
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
- All facilities operated by Alcon Laboratories, Inc.
- Alcon Canada (CA)
- Alcon Research, LLC (PA)
- Ciba Vision Asian Manufacturing and Logistics PTE, LTD (SG)
- CIBA VISION GMBH (DE)
- Alcon Research, LLC (CA)
- Alcon Research, LLC (GA)
- WAVELIGHT GmbH (DE)
- Alcon Research, LLC (TX)
- PT. CIBA VISION BATAM (ID)
- Alcon Research, LLC (CA)
- Alcon Research, LLC (WV)
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Alcon Research, LLC (FEI 1610287) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/1610287-alcon-research-llc/
Alerts for Alcon Research, LLC
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.